New Study Identifies NUAK1 as a Potential Target to Reduce…

New Study Identifies NUAK1 as a Potential Target to Reduce Heart Damage After a Heart Attack A groundbreaking study published in *Circulation Research* has uncovered a novel molecular pathway that may help protect the heart from damage following a heart attack. Researchers found that inhibiting a protein called NUAK1 significantly reduced ischemia-reperfusion injury, a major cause of cardiac tissue damage that occurs when blood flow is restored after a blockage. While restoring blood flow through procedures such as angioplasty or stenting is essential in treating acute myocardial infarction, the sudden return of oxygen-rich blood can paradoxically trigger additional injury to heart tissue. This phenomenon, known as ischemia-reperfusion (I/R) injury, contributes to cardiomyocyte death, adverse cardiac remodeling, and long-term heart failure risk. Finding therapies that limit reperfusion injury remains a major unmet need in cardiovascular medicine. The research team identified NUAK1, an AMPK-related kinase highly expressed in cardiomyocytes, as a key regulator of the